African American women have poor long-term survival following ischemic stroke

Neurology. 2006 Nov 14;67(9):1623-9. doi: 10.1212/01.wnl.0000242756.00084.f9.

Abstract

Objective: To determine racial and gender differences in long-term survival following ischemic stroke in a well-defined cohort of patients.

Methods: We analyzed the prospectively collected data from a randomized, placebo-controlled trial in patients with ischemic stroke presenting within 3 hours of symptom onset. We determined the effect of race and gender on 1-year survival ascertained by serial follow-ups using Kaplan-Meier analysis. Multivariate analysis was performed adjusting for age, initial NIH Stroke Scale (NIHSS) score, use of thrombolysis, time to randomization, stroke etiology, and other cardiovascular risk factors.

Results: Of the 547 patients with ischemic stroke, the 1-year survival (percentage +/- SE) for African American women (63 +/- 6%) was lower than white women (73 +/- 4%), African American men (79 +/- 4%), and white men (75 +/- 3%). Among the 209 patients younger than 65 years, the 1-year survival was prominently lower for African American women (66 +/- 8%) vs white women (87 +/- 5%), African American men (83 +/- 5%), and white men (89 +/- 3%). In the Cox proportional hazard analysis, African American women had a significantly higher rate of 1-year mortality (relative risk 2.1, 95% CI 1.2 to 3.5) after adjusting for all potential confounders except diabetes mellitus. After adjustment for diabetes mellitus, the difference became insignificant, although a 70% greater risk of 1-year mortality was still observed.

Conclusions: Compared with whites and men, African American women have a lower 1-year survival following ischemic stroke.

Publication types

  • Randomized Controlled Trial

MeSH terms

  • Adult
  • Aged
  • Black or African American / statistics & numerical data*
  • Brain Ischemia / ethnology
  • Brain Ischemia / mortality*
  • Brain Ischemia / physiopathology
  • Cardiovascular Diseases / epidemiology
  • Causality
  • Cohort Studies
  • Comorbidity
  • Diabetes Complications / epidemiology
  • Female
  • Follow-Up Studies
  • Humans
  • Male
  • Metabolic Syndrome / epidemiology
  • Middle Aged
  • Obesity / epidemiology
  • Placebo Effect
  • Prospective Studies
  • Sex Distribution
  • Smoking / epidemiology
  • Stroke / ethnology
  • Stroke / mortality*
  • Stroke / physiopathology
  • Survival Rate / trends
  • Tissue Plasminogen Activator / therapeutic use
  • United States / epidemiology
  • White People / statistics & numerical data*

Substances

  • Tissue Plasminogen Activator